Click here for slides on this topic


Atherosclerosis

A disorder of the arteries in which deposits (plaques) of cholesterol, lipids, and cellular debrisline the inner layers of arterial walls. It is a major cause of serious heart disease and associated with incresasing age, obesity, tobacco use, hypertension, elevated cholesterol, dyslipidemia, and diabetes.


The following content matched the glossary term: Atherosclerosis

Temporal trends in the population attributable risk for cardiovascular disease: The Atherosclerosis Risk in Communities Study

Top

Cheng S, Claggett B, Correia AW, et al. Temporal trends in the population attributable risk for cardiovascular disease: The Atherosclerosis Risk in Communities Study. Circulation. 2014;130:820-828.

T195-04

Top

Patient education handout exploring the connection between diabetes and cardiovascular disease.

European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013 - No Effect of Metformin on Atherosclerosis

Top

NDEI's coverage of the European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013 from Barcelona, Spain

 

European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013

Top

NDEI's coverage of the European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013 from Barcelona, Spain

Clinical Insights in Diabetes Newsletter July 2013

Top

Clinical Insights® in Diabetes newsletter July 2013

Carotid intima-media thickness (CIMT) change in ORIGIN-GRACE, effects of omega-3 fatty acids on CV events in the Risk and Prevention Study, canagliflozin therapy in CANTATA-D2 and CANTATA-M, weight gain and intensive therapy in ACCORD, glycemic control with single daily basal insulin plus corrective glulisine and basal bolus regimen, diurnal pattern to insulin action in type 1 diabetes.

American Heart Association (AHA) Scientific Sessions 2012

Top

Exclusive coverage of late-breaking data from the American Heart Association Scientific Sessions, November 3-7, 2012 in Los Angeles, California are featured in this issue of OnsiteInsight®.

Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: ORIGIN-GRACE

Top

Lonn EM, Bosch J, Diaz R, et al; for the GRACE and ORIGIN Investigators. Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the Glucose Reduction and Atherosclerosis Continuing Evaluation Study (ORIGIN-GRACE). Diabetes Care. 2013;36(9):2466-2474. Findings from ORIGIN-GRACE showed no difference in annualized change in maximum carotid intima-media thickness for 12 carotid artery segments with insulin glargine or omega-3 fatty acid.

OnsiteInsight November 2012

Top

The latest diabetes literature exploring diabetes guidelines, diabetes treatment, diabetes management, and diabetes prevention with commentary from diabetes experts.

Association of weight status with mortality in adults with incident diabetes

Top

Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308(6):581-590. Carnethon and colleagues analyzed data from five clinical trials to compare mortality rates among subjects who were normal weight with subjects who were overweight/obese at the time of incident adult-onset diabetes.

1 2 3 4 5 6 7 8 9 10  ... Next 

Slide Library Results

Search Results for: Atherosclerosis Slides Found: 39
Association Between Insulin Sensitivity and Physical Exercise The IRAS Study
Diabetes and Post-MI Survival in Two Ethnic Groups
Diabetes Is Undertreated Even When Atherosclerosis Present
IRAS: Number of CVD Risk Factors and Conversion to Type 2 Diabetes
ARIC: Association Between MetS Components and CHD Risk
PPARg Exerts Antiatherogenic Effects via Multiple Vascular Targets (animated)
IRAS: CVD Risk Factors Are Also Risk Factors for Type 2 Diabetes
IRAS: Risk of Type 2 Diabetes Based on Food-Pattern Score at Baseline
IRAS: Risk of Type 2 Diabetes by Food-Pattern Score and Obesity Status
BP and Type 2 Diabetes Risk in African Americans and Whites: Design
BP and Type 2 Diabetes Risk in African Americans and Whites: Results
Trends in CHD Risk Among Adults With Diabetes: Design
Trends in CHD Risk Among Adults With Diabetes: Results
High-Normal A1C as a Type 2 Diabetes Predictor: Design
High-Normal A1C as a Type 2 Diabetes Predictor: Results
ACCORD Substudy: Impact of Frequent and Unrecognized Hypoglycemia on Mortality—Design
ARIC: Role of A1C in Predicting Hypertension—Design
ARIC: Role of A1C in Predicting Hypertension—Results
Pooled Analysis: Mortality Among Normal and Overweight/Obese Subjects with Diabetes
Pooled Analysis: Mortality Rates Among Normal and Overweight/Obese Subjects with Diabetes
Pooled Analysis: Mortality Higher in Normal-Weight Subjects with Diabetes
Pooled Analysis: Mortality Among Normal and Overweight/Obese Subjects with Diabetes
VADT Post-hoc Analysis: Statin Use and Artery Calcification
Can Coronary Artery Calcium Predict CVD Outcomes in Type 2 Diabetes?
ORIGIN-GRACE: Design
ORIGIN-GRACE: Primary and Secondary Outcomes
ORIGIN-GRACE: Select Baseline Characteristics
ORIGIN-GRACE: No Difference in Annualized Change in Max CIMT for 12 Carotid Artery Segments with Glargine or Omega-3 Fatty Acid
ORIGIN-GRACE: Glargine, Not Omega-3 Fatty Acid, Improves Annualized Change in Max CIMT
ORIGIN-GRACE: No Difference in Annualized Change in Max Far Wall CIMT for Glargine or Omega-3 Fatty Acid
ORIGIN-GRACE: Major Cardiovascular Events
ORIGIN-GRACE: Summary of Findings
ORIGIN-GRACE: Eligibility Criteria and Trial Profile
ESH/ESC Hypertension Guidelines: Hypertension Treatment for Patients With Atherosclerosis, Arteriosclerosis, and PAD
ARIC Cardiovascular Risk Trends | NDEI
Hypertension Obesity Diabetes CVD Risk Factors in ARIC Study | NDEI
CVD Risk Trends ARIC Gender | NDEI
Trends in CVD Risk ARIC Study | NDEI
CVD Risk Trends By Race ARIC Study | NDEI